Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT06673602
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Qinhuangdao Hospital of Traditional Chinese Medicine
- Registry
-
NCT06673602
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06673602. Randomized; no masking; primary purpose treatment. Start 2024-11-04 (actual); primary completion 2026-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
- Condition
- Cognitive Impairment
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- FCYC+Conventional treatment
- Intervention (Drug)
- conventional treatment
- Lead sponsor
- Qinhuangdao Hospital of Traditional Chinese Medicine
- Collaborator
- Kaifeng Third People's Hospital
- Collaborator
- Second Affiliated Hospital of Tsinghua University
- Collaborator
- Weifang Hospital of Traditional Chinese Medicine
- Collaborator
- Shandong Public Health Clinical Center
- Collaborator
- Kunming Sanbo Brain Hospital
Record details
- Record id
cardio:ct-nct06673602- Content hash
91f9549926e323b2a7bcd7cd3dea3b6eed1a8ba44450c147f789cb602e2737dc